Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 1 AL 15

Physical exercise: a multi-target strategy for the prevention and treatment of Alzheimer's disease

Tong W.

Front Aging Neurosci. 2026 Oct 19;18:1876075. doi: 10.3389/fnagi.2026.1876075. eCollection 2026.

Plant-based diets, cognitive function, and Alzheimer's disease

Austin G, Ferguson JJA, Eslick S, Garg ML, Martins R.

Food Funct. 2026 Oct 19;17(20):8894-8912. doi: 10.1039/d6fo01946c.

Intermittent fasting as a therapeutic strategy in Alzheimer's disease: Understanding of brain-derived neurotrophic factor modulation

Shrirame D, Tatode A, Dabhade D, Taksande J, Taksande B, Kakade O, Umekar M.

Physiol Behav. 2026 Oct 8;318:115522. doi: 10.1016/j.physbeh.2026.115522. Online ahead of print.

Beyond the brain-centric view: A systems physiology framework for exercise-induced neuroprotection in Alzheimer's disease

Wan C, Wang F, Fan Y, Yang Y, Wei J.

Exp Neurol. 2026 Oct 10;408:116058. doi: 10.1016/j.expneurol.2026.116058. Online ahead of print.

Intelligent assistive technologies in rehabilitation for older adults with Alzheimer's disease: systematic review and thematic analysis

Yu M, He C, Shi L, Huang Z, Wang B, Liu Q, Cheng S.

Disabil Rehabil Assist Technol. 2026 Oct 13:1-32. doi: 10.1080/17483107.2026.2735597. Online ahead of print.

Therapeutic arts in Alzheimer disease: a brief review of evidence and mechanisms

Chakraborty S.

Dement Neuropsychol. 2026 Oct 12;20:e20250467. doi: 10.1590/1980-5764-DN-2025-0467. eCollection 2026.

Pyroptosis: a potential target and research progress of exercise in ameliorating Alzheimer's disease pathology

Jie S, Lei Z.

Front Aging Neurosci. 2026 Oct 7;18:1983962. doi: 10.3389/fnagi.2026.1983962. eCollection 2026.

Caregiver positivity as a psychosocial modifier of lecanemab-related outcomes in Alzheimer's disease: A multicenter longitudinal study in China

Wu W, Liu H, Liang Y, Li H, Zhang J, Sun Z, Song Y, Fei M, Wu H, Jiang M, Fan S, Zhou C, Cao Y, Chen H, Liu S.

Alzheimers Dement. 2026 Oct;22(10):e71894. doi: 10.1002/alz.71894.

The Role of the Glymphatic System in Alzheimer's Disease: Mechanisms, Evidence, and Therapeutic Implications

Li Y, Li J, Liu X, Wang T, Ma L, She R, Chang Y.

Rejuvenation Res. 2026 Oct;29(5):225-234. doi: 10.1177/15491684261442832. Epub 2026 Apr 14.

SHED-derived small extracellular vesicles as potential neuro-immune modulators in Alzheimer's disease

Ijaz A, Phothichailert S, Fitri AR, Zohaib S, Suwittayarak R, Kornsuthisopon C, Samaranayake L, Egusa H, Osathanon T.

J Oral Biosci. 2026 Oct;68(5):100811. doi: 10.1016/j.job.2026.100811. Epub 2026 Aug 25.

Non-pharmacological interventions for sleep improvement in Alzheimer's disease: A systematic review and meta-analysis

Zhang Q, Zhou Q, Yang M, Zou S, Li Y, Wang Z.

J Alzheimers Dis. 2026 Oct;113(4):1555-1569. doi: 10.1177/13872877261480066. Epub 2026 Sep 1.

Targeting Microglial Transcriptional Reprogramming as a Therapy Strategy for Alzheimer's Disease

Kim B, Wang SS, Kim JR, Kim J.

Bioessays. 2026 Oct;48(10):e70186. doi: 10.1002/bies.70186.

From pathogenesis to non-medical therapy: A review of exploring sensory and multi-sensory stimulation as a non-invasive treatment approach for Alzheimer's disease

Zhu Y, Jafari Z, Kolb BE, Mohajerani MH.

Neurosci Biobehav Rev. 2026 Dec;191:107004. doi: 10.1016/j.neubiorev.2026.107004. Epub 2026 Oct 7.

Advantage of cerebellar intermittent theta-burst stimulation in Alzheimer's disease (ACT-AD): study protocol for a multicenter, randomized, double-blind, sham-controlled trial

Zhang X, Li W, Sun Z, Wang X, Song C, Wang X, Niu Y, Wei D, Zhang W, Zhang G, Zhang B, Wang L, Liu Z, Zhao J, Jiang W.

Trials. 2026 Oct 9;27(1):601. doi: 10.1186/s13063-026-10009-w.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias